Moderna to fund coronavirus vaccine with $1.3 billion stock sale

Moderna is selling $1.3 billion in stock to help fund its promising new coronavirus vaccine. The biotech firm announced plans to sell 17.6 million shares priced at $76 apiece in a public offering that’s expected to close around Thursday. Net proceeds from the offering will cover costs related to the manufacturing of Moderna’s COVID-19 vaccine…